Home  >  Products  >  DGCR2 (DiGeorge syndrome critical region gene 2) Blocking Peptide (100ug)
DGCR2 (DiGeorge syndrome critical region gene 2) Blocking Peptide (100ug)

DGCR2 (DiGeorge syndrome critical region gene 2) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DGCR2 antibody (Catalogue #: ARP46576_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP46576
Size: 100 ug
Weight: 61kDa
Gene: 9993
Format: Lyophilized powder
Target: Deletions of the 22q11.2 have been associated with a wide range of developmental defects classified under the acronym CATCH 22. The DGCR2 is a novel putative adhesion receptor protein, which could play a role in neural crest cells migration, a process which has been proposed to be altered in DiGeorge syndrome. Deletions of the 22q11.2 have been associated with a wide range of developmental defects (notably DiGeorge syndrome, velocardiofacial syndrome, conotruncal anomaly face syndrome and isolated conotruncal cardiac defects) classified under the acronym CATCH 22. The DGCR2 gene encodes a novel putative adhesion receptor protein, which could play a role in neural crest cells migration, a process which has been proposed to be altered in DiGeorge syndrome.
Alternative names: DGS-C; DKFZp686I1730; IDD; KIAA0163; LAN; SEZ-12
See Full Product Listings >